B. Metzler seel. Sohn & Co’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,362
Closed -$917K 743
2025
Q3
$917K Sell
12,362
-13,400
-52% -$1.36M 0.01% 556
2025
Q2
$3.34M Buy
25,762
+7,075
+38% +$1.03M 0.03% 268
2025
Q1
$2.98M Buy
18,687
+5,262
+39% +$952K 0.03% 270
2024
Q4
$2.49M Buy
13,425
+4,285
+47% +$832K 0.03% 320
2024
Q3
$1.93M Buy
9,140
+477
+6% +$82.9K 0.02% 398
2024
Q2
$1.16M Buy
8,663
+2,015
+30% +$381K 0.01% 496
2024
Q1
$1.43M Buy
6,648
+1,784
+37% +$350K 0.02% 445
2023
Q4
$989K Buy
4,864
+378
+8% +$61.2K 0.01% 512
2023
Q3
$890K Buy
+4,486
New +$1.13M 0.01% 481

Other funds holding INSP

B. Metzler seel. Sohn & Co's INSP Position: Q4 2025 in Review

B. Metzler seel. Sohn & Co sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 12,362 shares — an estimated $917K sold.

B. Metzler seel. Sohn & Co first reported a position in INSP in Q3 2023 and held it in 9 quarters. The position peaked at $3.34M in Q2 2025. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • B. Metzler seel. Sohn & Co reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 12,362 Inspire Medical Systems shares in Q4 2025, an estimated $917K.
  • B. Metzler seel. Sohn & Co first reported a position in Inspire Medical Systems in Q3 2023 and held it in 9 quarters.
  • B. Metzler seel. Sohn & Co's Inspire Medical Systems position peaked at $3.34M in Q2 2025.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q4 2025, filed 28 Jan 2026.